HK1159650A1 - Antibody binding to envelope protein of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same - Google Patents

Antibody binding to envelope protein of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same

Info

Publication number
HK1159650A1
HK1159650A1 HK11113917.0A HK11113917A HK1159650A1 HK 1159650 A1 HK1159650 A1 HK 1159650A1 HK 11113917 A HK11113917 A HK 11113917A HK 1159650 A1 HK1159650 A1 HK 1159650A1
Authority
HK
Hong Kong
Prior art keywords
hepatitis
virus
same
antibody binding
envelope protein
Prior art date
Application number
HK11113917.0A
Other languages
English (en)
Chinese (zh)
Inventor
脇田隆字
赤澤悠子
中村紀子
Original Assignee
東麗株式會社
日本國立感染症研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東麗株式會社, 日本國立感染症研究所 filed Critical 東麗株式會社
Publication of HK1159650A1 publication Critical patent/HK1159650A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK11113917.0A 2008-09-30 2011-12-23 Antibody binding to envelope protein of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same HK1159650A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008254338 2008-09-30
PCT/JP2009/067051 WO2010038789A1 (ja) 2008-09-30 2009-09-30 Ｃ型肝炎ウイルスのエンベロープタンパク質２に結合する抗体及びそれを用いたｃ型肝炎ウイルスの遺伝子型の同定方法

Publications (1)

Publication Number Publication Date
HK1159650A1 true HK1159650A1 (en) 2012-08-03

Family

ID=42073548

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113917.0A HK1159650A1 (en) 2008-09-30 2011-12-23 Antibody binding to envelope protein of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same

Country Status (9)

Country Link
US (1) US8993228B2 (de)
EP (2) EP2862876B1 (de)
JP (1) JP5608087B2 (de)
CN (1) CN102227445B (de)
CA (1) CA2738982C (de)
DK (1) DK2862876T3 (de)
ES (1) ES2564586T3 (de)
HK (1) HK1159650A1 (de)
WO (1) WO2010038789A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2402032T3 (da) 2009-02-27 2019-11-04 Toray Industries Immunogen sammensætning
US8592559B2 (en) 2009-10-30 2013-11-26 Toray Industries, Inc. Antibody having activity of inhibiting hepatitis C virus (HCV) infection and use thereof
US10117463B2 (en) 2014-01-03 2018-11-06 Robert P Thomas, Jr. Vapor delivery device
CN109160942B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段502-518及其用途
CN109738648B (zh) * 2018-12-29 2021-09-17 山东莱博生物科技有限公司 稳定高效表达丙型肝炎病毒核心抗原抗体的工程细胞株及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569537B1 (de) 1991-01-31 1998-06-17 Abbott Laboratories Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
EP0947525A1 (de) 1998-03-27 1999-10-06 Innogenetics N.V. Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe
AU1462300A (en) * 1998-11-05 2000-05-22 Board Of Trustees Of The Leland Stanford Junior University Human pan-hcv human monoclonal antibodies
AU2002243259B2 (en) 2000-12-01 2008-02-07 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
CA2578021C (en) 2004-08-24 2014-11-18 Tokyo Metropolitan Organization For Medical Research Modified human hepatitis c virus genomic rna that can be autonomously replicated
ES2327432T3 (es) * 2004-10-29 2009-10-29 Intercell Ag Vacunas contra el vhc para pacientes con vhc cronica.
JP2008254338A (ja) 2007-04-05 2008-10-23 Bridgestone Corp タイヤの製造方法およびその装置

Also Published As

Publication number Publication date
JPWO2010038789A1 (ja) 2012-03-01
DK2862876T3 (en) 2016-05-23
US8993228B2 (en) 2015-03-31
EP2336173A1 (de) 2011-06-22
WO2010038789A1 (ja) 2010-04-08
CA2738982A1 (en) 2010-04-08
ES2564586T3 (es) 2016-03-23
EP2336173A4 (de) 2012-07-25
CN102227445A (zh) 2011-10-26
EP2862876A1 (de) 2015-04-22
CN102227445B (zh) 2014-12-17
CA2738982C (en) 2016-05-24
EP2862876B1 (de) 2016-03-02
JP5608087B2 (ja) 2014-10-15
US20110201014A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
EP2099825A4 (de) Rekombinante antikörper gegen den hepatitis c-virus und verfahren zu deren erhalt und verwendung davon
HRP20170024T1 (hr) Antigeni peptidi gm-csf i protutijela protiv gm-csf
IL248723B (en) Specific antibodies against the bcr complex and methods of using them
HK1144440A1 (en) Hepatitis c virus antibodies
EP2350655A4 (de) Verfahren zur verwendung von antikörpern und analoga daraus
EP2282770A4 (de) Antikörper mit veränderter bindung an fcnr und verwendungsverfahren dafür
HK1191865A1 (zh) 白細胞介素- α抗體及使用方法
EP2304440A4 (de) Neue monoklonale antikörper gegen hpv-proteine
EP2193145A4 (de) Zusammensetzungen und verfahren mit bindungsproteinen für adalimumab
HK1156226A1 (en) Compositions and methods for antibodies against complement protein c5 c5
EP2035565A4 (de) Verfahren zur erweiterung der proteininkorporation in virusähnlichen partikeln
IL178761A0 (en) Antibodies and molecules derived therefrom that bind to steap-1 proteins
EP2262832A4 (de) Monoklonale antikörper gegen ebola- und marburg-viren
HK1138297A1 (en) Human antibodies against hepatitis c virus (hcv) uses thereof (hcv)
IL186385A0 (en) Antibodies and molecules derived therefrom that bind to 161p2f10b proteins
PL2283026T3 (pl) Sposób wzbogacania i izolowania biomolekuł lub wirusów
GB0718843D0 (en) Materials and methods relating to modifying the binding of antibodies
EP2265646A4 (de) Reagenzien und verfahren zum nachweis von grippevirusproteinen
HK1159650A1 (en) Antibody binding to envelope protein of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same
EP2147118A4 (de) Materialien und verfahren zum nachweis von hepatitis-c-virus
EP2088431A4 (de) Verfahren zur analyse des hepatitis-b-virus-s-antigens
EP2004684A4 (de) Das hepatitis-c-virus neutralisierende antikörper
EP1885893A4 (de) Verfahren zur bestimmung der immunverstärkung von virusinfektivität mit fc-rezeptor-transfizierten zelllinien
ZA200609068B (en) Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181002